CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
sertraline (Zoloft)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00229476
NCT00229476Phase 4Completed
CompareCT.gov

Study of Medication and Placebo Response in Major Depression

University of California, Los Angeles·interventional·Posted Sep 29, 2005·Updated Nov 7, 2016

In Brief

A Phase 4 clinical trial evaluating sertraline (Zoloft) for Depressive Disorder, Major. Completed, across 1 site.

Detailed Summary

The primary purpose of the research study is to use recordings of brain electrical activity (through electroencephalogram, or EEG) and symptom measurements to determine whether patients are likely to show a response to medication or placebo treatment during a treatment trial for depression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepressive Disorder, Major
CountriesUnited States
CollaboratorsEli Lilly and Company, Pfizer, Massachusetts General Hospital

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 29, 2005
Enrollment StartDec 1, 2003
Primary CompletionMar 1, 2006
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 20.8 years ago

Interventions

sertraline (Zoloft)drug